Figure 1.
Kaplan‐Meier curves of overall survival between LCC and other NSCLCs. (a) (
) LCC, (
) LCNEC, (
) BSC, (
) SCC, (
) ADE, and for patients with LCC stratified by (b) age (
) ≤50, (
) 51‐60, (
) 61‐70, (
) 71‐80, (
) >80; (c) sex (
) Female, (
) Male; (d) stage (
) I, (
) II, (
) III, (
) IV; (e) primary site (
) upper lobe, (
) middle lobe, (
) lower lobe, (
) others; and (f) therapy (
) NT, (
) S, (
) C, (
) R, (
) S+C, (
) S+R, (
) C+R, (
) S+C+R. ADE, adenocarcinoma; BSC, basaloid squamous cell carcinoma; SCC, squamous cell carcinoma; LCC, large cell carcinoma; LCNEC, large cell neuroendocrine carcinoma; NSCLC, non‐small cell lung cancer; NT, no therapy; R, radiotherapy; S, surgery; C, chemotherapy.